HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

BACKGROUND: Cholangiocarcinoma is a rapidly fatal cancer entity with a median survival of less than one year. In contrast to many other malignancies, no substantial therapeutic breakthrough has been made in the past few decades, thereby limiting the treatment to cytotoxic chemotherapy with little be...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Thomas, Rausch, Melina, Rössler, Stephanie, Albrecht, Michael, Braun, Jana Dorothea, Geissler, Veronika, Mehrabi, Arianeb, Vogel, Monika Nadja, Pathil-Warth, Anita, Mechtersheimer, Gunhild, Renner, Marcus, Rupp, Christian, Weiss, Karl Heinz, Busch, Elena, Köhler, Bruno, Springfeld, Christoph, Schirmacher, Peter, Goeppert, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896712/
https://www.ncbi.nlm.nih.gov/pubmed/31805897
http://dx.doi.org/10.1186/s12885-019-6320-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896712/
https://www.ncbi.nlm.nih.gov/pubmed/31805897
http://dx.doi.org/10.1186/s12885-019-6320-y

Ejemplares similares